ロルラチニブ継続試験

基本情報

NCT ID

NCT05144997

ステータス

実施中（募集終了）

試験のフェーズ

第4相

試験タイプ

介入

目標被験者数

76

治験依頼者名

Pfizer

概要

The purpose of this protocol is to provide continued treatment access and safety follow-up for eligible participants who continue to derive a benefit from study intervention in the Pfizer sponsored lorlatinib parent studies that will be closed. Additional follow-up safety data collection will permit further characterization of the safety profile of lorlatinib in participants continuing to receive study intervention

対象疾患

介入

依頼者（Sponsor）

実施施設 (1)